Clinical Trial Update: Adjuvant Effect of Dexmedetomidine in Ultrasound (USG) Guided Transvers Abdominis Plane Block [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dexmedetomidine as an adjuvant in ultrasound-guided TAP block for preventing postoperative nausea and vomiting has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: Kırıkkale University | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: WITHDRAWN